Turn on more accessible mode

Turn off more accessible mode

Skip Ribbon Commands

Skip to main content

Turn off Animations

Turn on Animations

Pharma RFP/Invitation Notices

Terms and Conditions:

All RFP proposals must be submitted through the Ariba sourcing tool.
Your company must be registered in Singapore to participate in ALPS events.
For all events, the Supply Head requirement for participation is EPU/DAP/32.
Each Company must participate at all sourcing events through or using the same Ariba account.

You can gain direct access into events by following the steps outlined below:

Click on the respective link found in the column “Respond to Posting”. You will be directed to the next page
Click on the “Respond to Posting” button found on the page
Log in to Ariba by entering your Ariba ID and password
You will gain access into the event for proposal submission
Submit your proposal in the Ariba sourcing tool before the closing date and time stated in the RFP notice below

Contact Persons:

Chua Chye Juan (Tel: 6377 8733)
Maimunah Abdul Rahman (Tel: 6377 8732)
Nor'ain Mohd Yusoff (Tel: 6377 8734)

Purchasing Programme

Evaluation Criteria

RFP Results (Updated on 16 August 2019)

RFP/Invitation Notices

RFP No	Event Description	RFP Document	Published Date	Closing Date/time	Respond to Posting	Financial Category	Corrigendum	Remarks
GPOR 29219	Item 1 – Intravenous Immune Globulin for Intravenous use 2.5g (single dose vial) Item 2 – Intravenous Immune Globulin for Intravenous use 5g (single dose vial) Item 3 – Intravenous Immune Globulin for Intravenous use 10g (single dose vial)	GPOR 29219	16/08/2019	6/9/2019 12:00 PM	http://discovery.ariba.com/rfx/7145835	S9 or Higher	No
GPOR 29119	Item 1 – High purity Factor VIII concentrate containing approximately 250 IU per vial for the treatment of Factor VIII deficiency (single dose vial) Item 2 – Factor VIII Concentrate with von Willebrand’s Factor containing approximately 250-280 units per vial, for treatment of von Willebrand’s Disease (single dose vial) Item 3 - High purity Factor IX concentrate containing approximately 500 IU per vial for the treatment of Factor IX deficiency	GPOR 29119	16/08/2019	6/9/2019 12:00 PM	http://discovery.ariba.com/rfx/7145733	S4 or Higher	No
GPOR 29019	Item 1 – Anti-D (Rho) Immune Globulin (Human) 300mcg/dose Injection Item 2 – Hepatitis B Immune Globulin (Human), 0.5ml vial Item 3 – Hepatitis B Immune Globulin (Human), 5ml vial Item 4 – Human Rabies Immune Globulin 300 IU/2ml Injection Item 5 – Human Tetanus Immune Globulin 250 IU Injection	GPOR 29019	16/08/2019	6/9/2019 12:00 PM	http://discovery.ariba.com/rfx/7145596	S3 or Higher	Yes	This is due to WHC quantity is missed out from Items 3 and 5 of the RFP. Therefore the total quantity for Items 3 and 5 need to be changed from 171 to 172 vials and 113 to 115 vials.
GPOR 28919	Item 1 – Human Albumin Solution 5% w/v for intravenous administration, 250ml vial Item 2 – Human Albumin Solution 20% w/v for intravenous administration, 50ml vial	GPOR 28919	16/08/2019	6/9/2019 12:00 PM	http://discovery.ariba.com/rfx/7145495	S7 or Higher	No
GPOR 28819	Item 1 – Coombs Reagent, Anti-Human Globulin (Polyspecific), 10ml bottle	GPOR 28819	16/08/2019	6/9/2019 12:00 PM	http://discovery.ariba.com/rfx/7145022	S2 or Higher	No
GPOR 28719	Item 1 – Anti-A Blood Grouping Serum, 10ml bottle Item 2 – Anti-A and Anti-B (Group O) Blood Grouping Serum, 10ml bottle Item 3 – Anti-B Blood Grouping Serum, 10ml bottle Item 4 – Anti-D Blood Grouping Serum (RH 1), 10ml bottle	GPOR 28719	16/08/2019	6/9/2019 12:00 PM	http://discovery.ariba.com/rfx/7144958	S2 or Higher	No
GPOR 28619	Item 1 – Anti-C Blood Grouping Serum (RH 2), 5ml bottle Item 2 – Anti-c Blood Grouping Serum (RH 4), 5ml bottle Item 3 – Anti-CDE Blood Grouping Serum (RH 2, 1, 3), 5ml bottle Item 4 – Anti-E Blood Grouping Serum (RH 3), 5ml bottle Item 5 – Anti-e Blood Grouping Serum (RH 5), 5ml bottle Item 6 – Low Ionic Strength Saline (LISS) Solution, 10ml bottle	GPOR 28619	16/08/2019	6/9/2019 12:00 PM	http://discovery.ariba.com/rfx/7144902	S2 or Higher	No
GPOR 28519	Item 1 - Itraconazole 10mg/ml Oral Solution, 150ml bottle	GPOR 28519	08/08/2019	30/8/2019 12:00 PM	http://discovery.ariba.com/rfx/7024272	S2 or Higher	No
GPOR 28419	Item 1 - Recombinant Factor VIII 250 IU Injection Item 2 - Recombinant Factor VIII 500 IU Injection Item 3 - Recombinant Factor VIII 1000 IU Injection Item 4 - Recombinant Factor VIII 1500 IU Injection Item 5 - Recombinant Factor VIII 2000 IU Injection	GPOR 28419	08/08/2019	30/8/2019 12:00 PM	http://discovery.ariba.com/rfx/7113808	S5 or Higher	No
GPOR 28319	Item 1 - Recombinant Factor VIIa (Eptacog Alfa) 1mg Injection	GPOR 28319	08/08/2019	30/8/2019 12:00 PM	http://discovery.ariba.com/rfx/7113730	S4 or Higher	No
GPOR 28219	Item 1 - Recombinant Factor IX 500 IU Injection	GPRO 28219	08/08/2019	30/8/2019 12:00 PM	http://discovery.ariba.com/rfx/7113475	S5 or Higher	No
GPOR 28119	Item 1 - Risedronate Sodium 150mg Tablets	GPOR 28119	08/08/2019	30/8/2019 12:00 PM	http://discovery.ariba.com/rfx/7112234	S2 or Higher	No
GPOR 28019	Item 1 - Ambrisentan 5mg Tablets Item 2 - Ambrisentan 10mg Tablets	GPOR 28019	02/08/2019	20/8/2019 12:00 PM	http://discovery.ariba.com/rfx/7085472	S2 or Higher	No
GPOR 27919	Item 1 - Infliximab 100mg Injection	GPOR 27919	02/08/2019	23/8/2019 12:00 PM	http://discovery.ariba.com/rfx/7085441	S4 or Higher	No